Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

Cancer Research

Volumn 66, Issue 8, 2006, Pages 4488-4495

  Valzasina, Barbara ^a   Piconese, Silvia ^a   Guiducci, Cristiana ^a   Colombo, Mario P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD3 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLON CARCINOMA; CONTROLLED STUDY; EFFECTOR CELL; LYMPH NODE; LYMPH NODE CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE; THYMECTOMY; THYMUS; UNDIFFERENTIATED CARCINOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; COLONIC NEOPLASMS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-2; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMECTOMY; THYMUS GLAND;

EID: 33646239606     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4217     Document Type: Article

References (53)

1. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2:301-6.
2. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62.
3. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
4. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
5. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-23.
6. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-42.
7. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of 0X40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for 0X40 and its comparison with GITR. Blood 2005;105:2845-51.
8. + regulatory T cells. J Exp Med 2004;199:303-13.
9. + regulatory T cells. Nat Immunol 2003;4:330-6.
10. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002;17:167-78.
11. + T cell numbers. J Immunol 2002;169:4850-60.
12. Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-61.
13. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005;65:2457-64.
14. Woo EY, Chu CS, Goletz TJ, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-72.
15. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-99.
16. + regulatory T cell proliferation. J Exp Med 2005;202:919-29.
17. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002;32:3267-75.
18. + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun 2002;2:1.
19. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-8.
20. Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-32.
21. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 2004;200:771-82.
22. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-8.
23. + proportion in spleen of tumor-bearing BALB/c mice. J Transl Med 2005;3:5.
24. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9:606-12.
25. + immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 2002;80:567-73.
26. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 2005;102:4091-6.
27. + T cells. J Exp Med 1993;178:237-44.
28. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-71.
29. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 2002;169:2461-5.
30. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005;201:127-37.
31. Colombo MP, Parenza M, Parmiani G. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells. Cancer Immunol Immunother 1985;20:198-204.
32. + regulatory T cells by peripheral expansion. J Immunol 2004;173:7259-68.
33. + regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J Immunol 2006;176:1750-8.
34. + regulatory T cells. J Immunol 2005;174:90-8.
35. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002;3:756-63.
36. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001;167:188-95.
37. + T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000;164:240-7.
38. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004;104:3804-12.
39. Siegmund K, Feuerer M, Siewert C, et al. Migration matters: regulatory T cell compartmentalization determines suppressive activity in vivo. Blood 2005;106:3097-104.
40. + regulatory T cells protects from lethal acute GVHD. Blood 2005;105:2220-6.
41. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
42. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-61.
43. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-8.
44. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003;198:1875-86.
45. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-53.
46. Boggio K, Nicoletti G, Di Carlo E, et al. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 1998;188:589-96.
47. McEarchern JA, Kobie JJ, Mack V, et al. Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int J Cancer 2001;91:76-82.
48. Pasche B. Role of transforming growth factor β in cancer. J Cell Physiol 2001;186:153-68.
49. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-27.
50. Lucas PJ, Kim SJ, Melby SJ, Gress RE. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor. J Exp Med 2000;191:1187-96.
51. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
52. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 2005;201:779-91.
53. + regulatory T cells. J Exp Med 2005;202:885-91.